From steatosis to inflammation: Innate lymphocytes as hidden orchestrators in metabolic dysfunction-associated steatotic liver disease

Read full text Summarise with VIRAT
Authors: César Alejandro San Juan-García, Rita I Escamilla, Lucia Cruz-Romero, Christian David Hernández-Silva, David Fernández-Quezada, Ulises De la Cruz-Mosso, Ana Laura Pereira-Suárez, Jesse Haramati, Inocencia Guadalupe Ramírez-López, José Macías‐Barragán, Montoya Buelna Margarita
Cited by: 0
References: 68

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a progressive condition that ranges from simple hepatic steatosis to steatohepatitis, persistent inflammation, and fibrosis. Although metabolic alterations and hepatocellular injury are established as central drivers of MASLD, accumulating evidence underscores the pivotal contribution of innate and innate-like lymphocytes in modulating immune responses throughout disease progression. Among these, gamma delta T cells, natural killer cells, natural killer T cells, innate lymphoid cells, and mucosal-associated invariant T cells are highly represented in the liver and rapidly respond to metabolic stress and inflammatory stimuli. These populations promote cytokine secretion, hepatocyte injury, recruitment of additional immune subsets, and activation of hepatic stellate cells, thereby sustaining inflammation and tissue remodeling. Depending on the disease stage and the surrounding microenvironment, they may exert either protective or pathogenic roles, ultimately determining whether the process resolves or progresses toward fibrosis. This review provides an overview of their phenotypic features, effector mechanisms, and interactions within the hepatic immune microenvironment, highlighting their potential as diagnostic biomarkers and therapeutic targets in MASLD and its complications.

Fields of Study & Subjects

Liver Disease Diagnosis and Treatment Liver physiology and pathology Liver Diseases and Immunity

Publication details

Journal / source
World Journal of Hepatology
Volume
18
Issue
3
Publication date
26 March 2026
Language
EN